Dirk Garmann
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Hemophilia Treatment and Research
Papers in
-
- Hemophilia Treatment and Research 5
-
- Atrial Fibrillation Management and Outcomes 4
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Ulrich Jaehde (4 shared papers)André Warnecke (2 shared papers)Felix Kratz (2 shared papers)Ganna V. Kalayda (2 shared papers)Alexander Solms (11 shared papers)Iduna Fichtner (1 shared paper)Thomas Eißing (5 shared papers)Anita Shah (3 shared papers)
- Journals
- Clinical Pharmacokinetics (7 papers)CPT Pharmacometrics & Systems Pharmacology (6 papers)Journal of Thrombosis and Thrombolysis (2 papers)The Journal of Clinical Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Dirk Garmann
30 papers receiving 558 citations
Peers
Comparison fields: 5 of 78
- Internal Medicine 39
- Hematology 110
- Oncology 134
- Cardiology and Cardiovascular Medicine 96
- Endocrinology, Diabetes and Metabolism 54
Countries citing papers authored by Dirk Garmann
This map shows the geographic impact of Dirk Garmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Garmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Garmann more than expected).
Fields of papers citing papers by Dirk Garmann
This network shows the impact of papers produced by Dirk Garmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Garmann. The network helps show where Dirk Garmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Garmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 92 | |
| 2 | 2008 | 75 | |
| 3 | 2018 | 53 | |
| 4 | 2011 | 35 | |
| 5 | 2017 | 32 | |
| 6 | 2018 | 29 | |
| 7 | 2021 | 29 | |
| 8 | 2016 | 28 | |
| 9 | 2019 | 26 | |
| 10 | 2021 | 24 | |
| 11 | 2019 | 20 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2023 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 9 | |
| 18 | 2019 | 8 | |
| 19 | 2010 | 8 | |
| 20 | 2019 | 7 |
About Dirk Garmann
Dirk Garmann is a scholar working on Hematology, Cardiology and Cardiovascular Medicine, Molecular Biology, Internal Medicine and Oncology, having authored 30 papers that have together received 563 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Hormonal Regulation and Hypertension (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Metal complexes synthesis and properties (3 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Internal Medicine (39 citations), Hematology (110 citations), Oncology (134 citations), Cardiology and Cardiovascular Medicine (96 citations) and Endocrinology, Diabetes and Metabolism (54 citations). Dirk Garmann has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Ulrich Jaehde, André Warnecke, Felix Kratz, Ganna V. Kalayda, Alexander Solms, Iduna Fichtner, Thomas Eißing, Anita Shah, Bart A. Ploeger and Stefan Willmann. Their work appears in journals such as Clinical Pharmacokinetics, CPT Pharmacometrics & Systems Pharmacology, Journal of Thrombosis and Thrombolysis, The Journal of Clinical Pharmacology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.